949-492-9944

Reglan, also called metoclopramide, is a drug commonly prescribed to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), persistent heartburn, nausea, vomiting, and a feeling of stomach fullness. However, the drug has been shown to cause tardive dyskinesia, a permanent and severe condition which causes uncontrollable movement of the extremities and the face.

Reglan is used to treat nausea, vomiting, and heartburn caused by gastric reflux. The FDA approved Reglan for a short-term use of 4-12 weeks. Approximately 1/3 of Reglan users have been prescribed it for more than 12 weeks. This extended usage put the patient at greater risk of Tardive Dyskinesia. Although the label mentions tardive dyskinesia, it indicated that the occurrence is rare. Unfortunately, 27-29 percent of long-term Reglan users have developed Tardive Dyskinesia.

If you are the parent of a child who took Reglan to treat gastroesophageal reflux disease (GERD) then you may be concerned. Your child may have developed or be at risk of developing infant tardive dyskinesia. Tardive dyskinesia causes a person to have involuntary bodily movements that can interfere with daily living and may cause social problems. Tardive dyskinesia is often irreversible and an infant who develops the condition from the use of drugs such as Reglan may face a lifetime of dealing with the effects of the condition.

In the case of drug litigation, you would be facing very wealthy and powerful pharmaceutical companies. This means you will need the best and most experienced legal representation you can find. An experienced Reglan attorney from John Anderson Law will have detailed information about Reglan side effects, FDA warnings, and specialized knowledge about how to handle the procedural details of your case.